ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Return on equity 2018–2025
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-30.7%FY2025 · since FY2018: -159.7% → -30.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -30.7% | +2.8 pp |
| FY2024 | -33.6% | -22.9 pp |
| FY2023 | -10.7% | -14.1 pp |
| FY2022 | 3.5% | +92.7 pp |
| FY2021 | -89.2% | -71.1 pp |
| FY2020 | -18.2% | +82.6 pp |
| FY2019 | -100.8% | +58.9 pp |
| FY2018 | -159.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ARCT financial trends
ARCT RevenueARCT Net incomeARCT Net marginARCT Gross profitARCT Gross marginARCT Operating incomeARCT Operating marginARCT Operating cash flowARCT Free cash flowARCT Capital expendituresARCT Stock buybacksARCT Dividends paidARCT Total assetsARCT Total liabilitiesARCT Shareholders’ equityARCT overview →